Comparative Efficacy of Transdermal Forms for Alopecia Therapy

December 2021 in “ Razrabotka i registraciâ lekarstvennyh sredstv ”

U. V. Nogaeva, D. Yu. Ivkin, Г. А. Плиско, E. V. Flisyuk, V. E. Kovanskov, Yu. G. Shtyrlin, К. О. Сидоров

transdermal forms alopecia therapy substance Y gel alcohol oil minoxidil burdock oil hair follicles growth phase 2% minoxidil solution topical alopecia therapy Rogaine

Studysummary This study found that the gel form of substance Y led to more hair follicles in the growth phase than 2% minoxidil solution when applied for alopecia treatment in mice.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The study investigated the efficacy of a new substance Y in various transdermal forms (gel, alcohol, and oil) for treating alopecia, compared to minoxidil and burdock oil, using male C57BL/6 mice. Results showed that the gel form of substance Y was the most effective, leading to a higher number of hair follicles in the growth phase than the 2% minoxidil solution, with statistically significant differences. However, substance Y did not exhibit antioxidant activity. The findings suggest that the gel form of substance Y is promising for topical alopecia therapy, with plans for further mechanism studies and patent registration.

View this study on pharmjournal.ru →

Discuss this study in the Community →

Research cited in this study

8 / 8 results

research Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence

19 citations , May 2021 in “Clinical, Cosmetic and Investigational Dermatology”

This review discusses the progress in research on topical formulations for treating alopecia, highlighting potential advantages of advanced formulation technologies but reporting no new clinical results.

research Physiology and Medical Treatments for Alopecia

8 citations , April 2020 in “Facial Plastic Surgery Clinics of North America”

This abstract explains that androgenetic alopecia, a common hair loss disorder influenced by genetics and hormones like dihydrotestosterone, has FDA-approved treatments including minoxidil, finasteride, and photolaser therapy, but its genetic basis and susceptibility to environmental factors remain complex.

research Alopecia: From Clinic to Preclinic and Back

1 citations , December 2019 in “Formuly farmacii”

This article reviews the complex etiology of alopecia and emphasizes the need for detailed pathogenesis studies in animal models to develop effective personalized treatments, without presenting new experimental data.

research Off-Label Use of Topical Minoxidil in Alopecia: A Review

32 citations , January 2019 in “American Journal of Clinical Dermatology”

This review discusses the use of topical minoxidil for various types of alopecia and reports mixed evidence on its efficacy, with stronger support noted for conditions like eyebrow hypotrichosis and chemotherapy-induced alopecia.

research Minoxidil in Trichological Practice

1 citations , April 2018 in “Медицинский совет”

In this review, the authors report that topical minoxidil effectively stimulates hair growth in androgenic alopecia and to a lesser extent in nasal alopecia, particularly in early stages, with minimal and typically short-lived adverse skin reactions, but no systemic side effects.

research Hair Growth Promotion Effect of Cedrol Cream and Its Dermatopharmacokinetics

11 citations , January 2018 in “RSC Advances”

Cedrol cream is more effective and safe for promoting hair growth than traditional treatments.

research Comparison of Saccharina Japonica–Undaria Pinnatifida Mixture and Minoxidil on Hair Growth Promoting Effect in Mice

9 citations , November 2016 in “Archives of Plastic Surgery”

In this study, researchers found that a mixture of Saccharina japonica and Undaria pinnatifida (L-U mixture) promoted hair growth in mice comparably to 3% minoxidil. The L-U mixture stimulated hair growth-promoting genes and suppressed hair loss-related genes, suggesting its potential for hair loss treatments.

research 2% Topical Minoxidil Solution in Male-Pattern Baldness: Preliminary European Results

26 citations , January 1987 in “Dermatology”

This study reported that topical 2% minoxidil solution improved hair growth compared to placebo in men with early male-pattern baldness over 24 weeks, with no significant safety issues observed.